BiotechTube
Home/Pipeline/Biosimilar/Biotech Programs

Biosimilar/Biotech Programs

Not Specified

ResearchActive

Key Facts

Indication
Not Specified
Phase
Research
Status
Active
Company
Deva Holdings

About Deva Holdings

Founded in 1958, Deva Holdings has grown from a domestic Turkish pharmaceutical player into an internationally recognized, publicly traded generics and API manufacturer. Its strategy is built on vertical integration, a strong R&D focus on bioequivalence, and geographic expansion into over 80 countries. Key achievements include establishing a significant export business, maintaining a diverse portfolio spanning multiple therapeutic areas, and operating a large-scale, end-to-end production infrastructure. The company's mission, 'For lives we add health to...', underscores its commercial focus on affordable, accessible medicine.

View full company profile

Therapeutic Areas

CardiovascularCentral Nervous SystemAnti-infectivesOncology Supportive CareDermatologyConsumer Health

Other Not Specified Drugs

DrugCompanyPhase
New TCM FormulationsChina SXT PharmaceuticalsResearch / Pre-clinical
Long-acting LeronlimabCytoDynPreclinical
Collaborative Program with FerringPharmaBiomeResearch
Lighthouse Pilot ProductCipheromePilot
Nitric Oxide + Collagen DeliveryJellagenResearch
UndisclosedAutheraPre-clinical
BP1003Bio-Path HoldingsPreclinical
mRNA Therapeutics Platform ApplicationLupagenResearch
PHYRAGOHanda PharmaceuticalsApproved
TASCENSO ODTHanda PharmaceuticalsApproved
AxulinHousey Pharmaceutical Research LaboratoriesCommercial
PBI-04711Phoenix BiotechnologyPre-clinical